153 related articles for article (PubMed ID: 28976022)
1. Development and validation of prognostic survival models in newly diagnosed Parkinson's disease.
Macleod AD; Dalen I; Tysnes OB; Larsen JP; Counsell CE
Mov Disord; 2018 Jan; 33(1):108-116. PubMed ID: 28976022
[TBL] [Abstract][Full Text] [Related]
2. Predictors of functional dependency in Parkinson's disease.
Macleod AD; Counsell CE
Mov Disord; 2016 Oct; 31(10):1482-1488. PubMed ID: 27548693
[TBL] [Abstract][Full Text] [Related]
3. Development and external validation of a prognostic model in newly diagnosed Parkinson disease.
Velseboer DC; de Bie RM; Wieske L; Evans JR; Mason SL; Foltynie T; Schmand B; de Haan RJ; Post B; Barker RA; Williams-Gray CH
Neurology; 2016 Mar; 86(11):986-93. PubMed ID: 26888991
[TBL] [Abstract][Full Text] [Related]
4. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
5. Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease.
Ramsay N; Macleod AD; Alves G; Camacho M; Forsgren L; Lawson RA; Maple-Grødem J; Tysnes OB; Williams-Gray CH; Yarnall AJ; Counsell CE; ; ; ; ; ; ; ;
Parkinsonism Relat Disord; 2020 Jul; 76():49-53. PubMed ID: 32645619
[TBL] [Abstract][Full Text] [Related]
6. Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations.
Schrag A; Anastasiou Z; Ambler G; Noyce A; Walters K
Mov Disord; 2019 Apr; 34(4):480-486. PubMed ID: 30735573
[TBL] [Abstract][Full Text] [Related]
7. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
8. Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism.
Vignatelli L; Zenesini C; Belotti LMB; Baldin E; Bonavina G; Calandra-Buonaura G; Cortelli P; Descovich C; Fabbri G; Giannini G; Guarino M; Pantieri R; Samoggia G; Scaglione C; Trombetti S; D'Alessandro R; Nonino F;
Mov Disord; 2021 Jan; 36(1):1-10. PubMed ID: 33196119
[TBL] [Abstract][Full Text] [Related]
9. REM sleep behavior disorder predicts functional dependency in early Parkinson's disease.
Kim R; Yoo D; Im JH; Kim HJ; Jeon B
Parkinsonism Relat Disord; 2019 Sep; 66():138-142. PubMed ID: 31371182
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for early mortality in Parkinson's disease.
Oosterveld LP; Allen JC; Reinoso G; Seah SH; Tay KY; Au WL; Tan LC
Parkinsonism Relat Disord; 2015 Mar; 21(3):226-30. PubMed ID: 25572499
[TBL] [Abstract][Full Text] [Related]
11. The incidence of Parkinson's disease in the North-East of England.
Duncan GW; Khoo TK; Coleman SY; Brayne C; Yarnall AJ; O'Brien JT; Barker RA; Burn DJ
Age Ageing; 2014 Mar; 43(2):257-63. PubMed ID: 23880142
[TBL] [Abstract][Full Text] [Related]
12. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
Williams-Gray CH; Mason SL; Evans JR; Foltynie T; Brayne C; Robbins TW; Barker RA
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1258-64. PubMed ID: 23781007
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study.
Alves G; Müller B; Herlofson K; HogenEsch I; Telstad W; Aarsland D; Tysnes OB; Larsen JP;
J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):851-7. PubMed ID: 19246476
[TBL] [Abstract][Full Text] [Related]
14. Co-morbidity burden in Parkinson's disease: Comparison with controls and its influence on prognosis.
Macleod AD; Goddard H; Counsell CE
Parkinsonism Relat Disord; 2016 Jul; 28():124-9. PubMed ID: 27210815
[TBL] [Abstract][Full Text] [Related]
15. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
[TBL] [Abstract][Full Text] [Related]
16. Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort.
Lawton M; Baig F; Toulson G; Morovat A; Evetts SG; Ben-Shlomo Y; Hu MT
Mov Disord; 2020 Feb; 35(2):279-287. PubMed ID: 31693246
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study.
Hiorth YH; Alves G; Larsen JP; Schulz J; Tysnes OB; Pedersen KF
J Neurol; 2017 Feb; 264(2):364-372. PubMed ID: 28000003
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Sex-Specific Survival on the Incidence of Dementia in Parkinson's Disease.
Fink A; Dodel R; Georges D; Doblhammer G
Mov Disord; 2023 Nov; 38(11):2041-2052. PubMed ID: 37658585
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Swedish Patient-Reported Outcomes in Parkinson's Disease Scale in Outpatients.
von Below D; Wallerstedt SM; Bergquist F
Mov Disord; 2023 Sep; 38(9):1668-1678. PubMed ID: 37382300
[TBL] [Abstract][Full Text] [Related]
20. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
